SpyGlass Pharma, Inc. Common Stock
Status: Publicly traded
Direct answer
SpyGlass Pharma, Inc. Common Stock is publicly traded on NASDAQ under the ticker SGP.
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients...
Can you invest in SpyGlass Pharma, Inc. Common Stock?
Yes. SpyGlass Pharma, Inc. Common Stock trades publicly on NASDAQ as SGP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SpyGlass Pharma, Inc. Common Stock
Detailed equity research is provided by MarketSnap.